肾移植受者C端成纤维细胞生长因子23、铁缺乏与死亡率的关联
该研究在700例稳定肾移植受者中检测血浆iFGF23和cFGF23水平,发现铁缺乏者cFGF23中位数显著高于无铁缺乏者,而iFGF23无差异。铁缺乏与死亡率增加相关,但校正cFGF23后关联不再显著,中介分析显示cFGF23解释了46%的关联。
要点
- 在肾移植受者中,铁缺乏者cFGF23水平显著升高,iFGF23水平无差异。
- 铁缺乏与死亡风险增加相关,校正cFGF23后该关联失去显著性。
- cFGF23可能介导铁缺乏与死亡率的关联,解释比例达46%。
核心结论
- 在肾移植受者中,铁缺乏者cFGF23水平升高,cFGF23可能介导铁缺乏与死亡率之间的关联。
研究设计与样本
- 研究纳入700例稳定肾移植受者,移植后中位时间5.4年,检测血浆iFGF23和cFGF23水平,并进行多变量校正Cox回归和中介分析。
主要发现
- 铁缺乏受者cFGF23中位数(四分位距)为223(131-361)RU/ml,高于无铁缺乏者的124(88-180)RU/ml,P<0.001;两组iFGF23浓度相似。
- 多变量校正Cox回归中,铁缺乏与死亡率增加相关(81例事件;风险比1.95;95%置信区间1.22至3.10;P<0.01)。
- 进一步校正cFGF23水平后,铁缺乏与死亡率的关联失去显著性(风险比1.45;95%置信区间0.87至2.51;P=0.15)。
- 中介分析显示,cFGF23解释了铁缺乏与死亡率关联的46%,而iFGF23未介导该关联。
临床怎么用
- 在肾移植受者中评估铁缺乏时,可关注cFGF23水平,其可能帮助识别铁缺乏相关死亡风险较高的患者。
局限性
- 研究为观察性设计,无法确立因果关系;中介分析结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Iron deficiency (ID) is independently associated with an increased risk of death in renal transplant recipients (RTRs). ID promotes production and cleavage of intact fibroblast growth factor 23 (iFGF23) into C-terminal fibroblast growth factor 23 (cFGF23), elevated levels of which are also prospectively associated with adverse outcomes. We hypothesized that in RTRs, the relationship between ID and mortality is mediated by FGF23. We measured plasma iFGF23 and cFGF23 levels in 700 stable RTRs at a median of 5.4 years after transplant. RTRs with ID had median (interquartile range) cFGF23 concentrations higher than those of RTRs without ID (223 [131-361] versus 124 [88-180] RU/ml; P<0.001), whereas iFGF23 concentrations were similar between groups. In multivariable-adjusted Cox regression analyses, ID associated with increased mortality (81 events; hazard ratio, 1.95; 95% confidence interval, 1.22 to 3.10; P<0.01). However, this association lost significance after additional adjustment for cFGF23 levels (hazard ratio, 1.45; 95% confidence interval, 0.87 to 2.51; P=0.15). In further mediation analysis, cFGF23 explained 46% of the association between ID and mortality, whereas iFGF23 did not mediate this association. In conclusion, we found that cFGF23 levels are increased in iron-deficient RTRs and that the underlying biologic process driving production and cleavage of iFGF23, or alternatively the increased level of cFGF23 fragments, probably is an important mediator of the association between ID and mortality. Our results underline the strong relationship between iron and FGF23 physiology, and provide a potential mechanism explaining the relationship between ID and adverse outcome in RTRs.
引用
- Eisenga MF, van Londen M, Leaf DE, et al. C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients. J Am Soc Nephrol. 2017. PMID: 28774998. doi:10.1681/ASN.2016121350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。